This Philly-based company is using AI to predict which medical research can lead to profitable drugs and therapies Clarivate ...

Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...

U.S. prices for newly-launched pharmaceuticals more than doubled last year compared to 2021, as companies leveraged ...

The White House has released its long-awaited “MAHA Report” outlining the government’s target areas for addressing childhood ...

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

RAMAT GAN, Israel (AP) — RAMAT GAN, Israel (AP) — Galmed Pharmaceuticals Ltd. (GLMD) on Thursday reported a loss of $1.1 million in its first quarter. On a per-share basis, the Ramat Gan, Israel-based ...

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...

Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection in March. Regeneron Pharmaceuticals announced it ...

Regeneron is acquiring “substantially all” of 23andMe’s assets for $256 million following a bankruptcy auction.